(Tromsø 03. May 2017) Svein Lien, CEO of Biotec Pharmacon has purchased 20.000
shares in Biotec Pharmacon at NOK 6,18 per share via his fully owned company
Spiralen Industrier AS. After this transaction holds Svein Lien and associates
550.829 shares and 160.000 options in Biotec Pharmacon.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no

